Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
---|
05/09/2013 | US20130115163 Synthesis of mse-framework type molecular sieves |
05/08/2013 | CN103097381A 1, 8-naphthyridines as kinase inhibitors |
05/08/2013 | CN103087058A Method for recovery catalyst quinine used in meso cyclic anhydride desymmetrisation reaction |
05/08/2013 | CN103087057A Waste quinine recovery method |
05/07/2013 | US8436181 Production process of optically active 3-quinuclidinol derivative |
05/02/2013 | WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
05/02/2013 | CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative |
05/01/2013 | EP2585459A1 Alkaloid aminoester derivatives and medicinal compositions thereof |
05/01/2013 | EP2585458A1 Alkaloid aminoester derivatives and medicinal composition thereof |
05/01/2013 | EP2585457A1 Alkaloid aminoester derivatives and medicinal composition thereof |
04/25/2013 | US20130102592 Oxazole tyrosine kinase inhibitors |
04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
04/24/2013 | CN101735213B Optical isomer of penehyclidine and medicinal composition and application thereof |
04/23/2013 | CA2565632C Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
04/23/2013 | CA2529257C Methods and compositions for treating amyloid-related diseases |
04/18/2013 | US20130095193 Compounds useful as inhibitors of atr kinase |
04/17/2013 | CN102120740B Imidazoline compound chirally synthesized by using thiourea catalyst derived from rosin and application thereof in anti-inflammatory and antipyretic aspects |
04/10/2013 | CN101684118B Use of tricyclic compounds as glycine transport inhibitors |
04/10/2013 | CN101605784B Aza-bridged-ring compound |
04/03/2013 | CN103012396A Transfer method for isomers of palonosetron hydrochloride |
04/03/2013 | CN101597286B Organic catalyst containing primary amine, tertiary amine and urea or thiourea and preparation method thereof |
03/28/2013 | WO2013043961A1 Compounds useful as inhibitors of choline kinase |
03/28/2013 | WO2013043960A1 Compounds useful as inhibitors of choline kinase |
03/28/2013 | WO2013041655A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
03/28/2013 | US20130079521 Novel palonosetron salts and processes for preparation and purification thereof |
03/28/2013 | US20130079351 2-acylaminothiazole derivative or salt thereof |
03/28/2013 | CA2849442A1 Compounds useful as inhibitors of choline kinase |
03/28/2013 | CA2847186A1 Compounds useful as inhibitors of choline kinase |
03/28/2013 | CA2845720A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
03/27/2013 | EP2573079A2 Benzimidazole quinolinones and uses thereof |
03/27/2013 | EP2571874A1 A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
03/21/2013 | US20130072517 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
03/20/2013 | EP2570128A1 Muscarinic acetylcholine receptor antagonists |
03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
03/07/2013 | US20130060039 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
03/06/2013 | CN101851233B Palonosetron hydrochloride, and precursor compound thereof |
02/28/2013 | WO2013028999A1 Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders |
02/27/2013 | EP2562253A1 Modified carbonyl reductase, gene thereof, and method of producing optically active alcohols using these |
02/27/2013 | CN102947300A Alkaloid aminoester derivatives and medicinal compositions thereof |
02/27/2013 | CN102947299A Alkaloid aminoester derivatives and medicinal composition thereof |
02/27/2013 | CN102947298A Alkaloid aminoester derivatives and medicinal composition thereof |
02/27/2013 | CN101824033B Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
02/21/2013 | US20130045169 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
02/14/2013 | US20130040987 Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders |
02/13/2013 | CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
02/12/2013 | CA2570155C 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases |
02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
02/06/2013 | CN102212064B Method for preparing quinindium and cinchonine |
02/05/2013 | CA2520894C Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
01/31/2013 | US20130030184 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
01/31/2013 | US20130030015 Muscarinic acetylcholine receptor antagonists |
01/31/2013 | US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
01/31/2013 | US20130030001 Quinuclidine derivatives as muscarinic m3 receptor antagonists |
01/29/2013 | US8362008 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors |
01/29/2013 | CA2544492C Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
01/24/2013 | WO2013012827A1 Diaminocyclohexane compounds and uses thereof |
01/24/2013 | WO2013010916A1 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors |
01/24/2013 | WO2013010679A1 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors |
01/24/2013 | CA2841546A1 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors |
01/23/2013 | CN102887894A Crystal form of solifenacin succinate and preparation method thereof |
01/22/2013 | CA2583237C Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
01/22/2013 | CA2515777C Biphenyl derivatives |
01/17/2013 | US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
01/16/2013 | CN102875544A Preparation technology of solifenacin succinate |
01/15/2013 | US8354536 Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides |
01/10/2013 | WO2013004290A1 Cyclic amine derivatives as ep4 receptor antagonists |
01/10/2013 | CA2839116A1 Cyclic amine derivatives as ep4 receptor antagonists |
01/09/2013 | CN102863374A Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
01/09/2013 | CN101925600B Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester |
01/03/2013 | US20130005730 Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
01/03/2013 | US20130005695 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists |
01/02/2013 | EP2539336A2 Hetarylaminonaphthyridines |
01/02/2013 | EP2539335A1 Process for the preparation of isoxazoline derivatives |
01/02/2013 | EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
01/02/2013 | CN102850345A Quaternary ammonium salt and its pharmaceutical composition and its use |
01/02/2013 | CN102850344A Medicinal application of penehyclidine optical isomer derivative in anti-tumor |
12/27/2012 | WO2012175119A1 Process for the preparation of solifenacin and salts thereof |
12/26/2012 | EP2537830A1 Compounds and compositions as protein kinase inhibitors |
12/25/2012 | US8338429 2-acylaminothiazole derivative or salt thereof |
12/18/2012 | US8334388 Palonosetron salts and processes for preparation and purification thereof |
12/18/2012 | US8334303 Specifically mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate (SB 268091); use as antibiotic; crystallization from isopropanol; improved bioavailability, and/or physical properties, for example solubility or flow properties |
12/13/2012 | WO2012168359A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
12/13/2012 | US20120316341 Fluorination of organic compounds |
12/12/2012 | CN102822168A Process for the preparation of isoxazoline derivatives |
12/11/2012 | US8329934 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
12/11/2012 | US8329771 Photobase generator |
11/29/2012 | US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
11/28/2012 | CN101641350B Dibenzo[b, f][1, 4]oxazapine compounds |
11/27/2012 | CA2695742C Bicyclic amides for enhancing glutamatergic synaptic responses |
11/22/2012 | US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
11/15/2012 | US20120288501 Substituted benzazoles and methods of their use as inhibitors of raf kinase |
11/14/2012 | CN102781939A Palonosetron metabolites |
11/13/2012 | US8309572 Muscarinic acetylcholine receptor antagonists |
11/13/2012 | CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
11/07/2012 | CN102766140A Process for separating and preparing quinine sulfate from peruvian bark |
11/06/2012 | US8304545 Quinuclidine derivative useful in the preparation of mequitazine |
11/06/2012 | US8304544 Palonosetron free base and process for its preparation |
11/06/2012 | CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
11/01/2012 | WO2012146515A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof |